Jiang Qiao, Wang Li, Tian Jinlong, Zhang Weijia, Cui Huijun, Gui Hailong, Zang Zhihuan, Li Bin, Si Xu
College of Food Science, Shenyang Agricultural University, Shenyang, China.
State Key Laboratory of Food Science and Technology, Jiangnan University, Wuxi, China.
Crit Rev Food Sci Nutr. 2024 Nov;64(32):11701-11721. doi: 10.1080/10408398.2023.2242947. Epub 2023 Aug 7.
Extracellular vesicles (EVs) are naturally occurring non-replicating particles released from cells, known for their health-promoting effects and potential as carriers for drug delivery. Extensive research has been conducted on delivery systems based on culture-cell-derived EVs. Nevertheless, they have several limitations including low production yield, high expenses, unsuitability for oral administration, and safety concerns in applications. Conversely, food-derived EVs (FDEVs) offer unique advantages that cannot be easily substituted. This review provides a comprehensive analysis of the biogenesis pathways, composition, and health benefits of FDEVs, as well as the techniques required for constructing oral delivery systems. Furthermore, it explores the advantages and challenges associated with FDEVs as oral nanocarriers, and discusses the current research advancements in delivering active phytoconstituents. FDEVs, functioning as a nanocarrier platform for the oral delivery of active molecules, present numerous benefits such as convenient administration, high biocompatibility, low toxicity, and inherent targeting. Nevertheless, numerous unresolved issues persist in the isolation, characterization, drug loading, and application of FDEVs. Technical innovation and standardization of quality control are the key points to promote the development of FDEVs. The review aimed to provide frontier ideas and basic quality control guidelines for developing new functional food based on FDEVs oral drug delivery system.
细胞外囊泡(EVs)是细胞释放的天然存在的非复制性颗粒,以其促进健康的作用和作为药物递送载体的潜力而闻名。基于培养细胞衍生的EVs的递送系统已经进行了广泛的研究。然而,它们有几个局限性,包括产量低、成本高、不适用于口服给药以及应用中的安全性问题。相反,食物衍生的EVs(FDEVs)具有不易被替代的独特优势。本文综述全面分析了FDEVs的生物发生途径、组成和健康益处,以及构建口服递送系统所需的技术。此外,探讨了FDEVs作为口服纳米载体的优势和挑战,并讨论了目前在递送活性植物成分方面的研究进展。FDEVs作为口服活性分子递送的纳米载体平台,具有诸多优点,如给药方便、生物相容性高、毒性低和固有靶向性。然而,FDEVs的分离、表征、载药和应用仍存在许多未解决的问题。技术创新和质量控制标准化是促进FDEVs发展的关键点。本文综述旨在为基于FDEVs口服给药系统开发新型功能性食品提供前沿思路和基本质量控制指南。